NCT01206777
- Conditions
- Hypersensitivity, Immune System Diseases, Indolent or Intermediate Grade B-cell Malignancy
- Locations
-
- The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Indolent or Intermediate Grade B-cell Malignancy
Explore clinical trials studying Indolent or Intermediate Grade B-cell Malignancy. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies